CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +41,500 | 41,500 | ||
| 2025-01-03 | Duty Stuart Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-03 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-03 | Ribeiro Ramiro Chief Medical Officer | Grant or award · Restricted Stock Units | +59,000 | 59,000 | ||
| 2025-01-03 | Ribeiro Ramiro Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +117,000 | 117,000 | ||
| 2025-01-03 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +59,000 | 74,000 | ||
| 2025-01-03 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +117,000 | 117,000 | ||
| 2025-01-03 | Lurker Nancy Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-03 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-03 | Duker Jay S. President and CEO | Grant or award · Restricted Stock Units | +195,000 | 228,334 | ||
| 2025-01-03 | Duker Jay S. President and CEO | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2024-09-03 | Hassan Fred Director | Grant or award · Stock Options (Right to buy) | +60,000 | 60,000 | ||
| 2024-08-21 | ANDO GORAN Director | Purchase | +5,000 | $7.95 | $40K | 13,150 |
| 2024-08-20 | DICICCO WENDY F Director | Purchase | +2,567 | $7.79 | $20K | 9,967 |
| 2024-08-19 | Zaderej Karen L. Director | Purchase | +12,500 | $7.98 | $100K | 16,500 |
| 2024-08-16 | Lurker Nancy Director | Purchase | +3,173 | $7.88 | $25K | 97,635 |
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −1,558 | 0 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +1,558 | 74,800 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −26,713 | 31,165 | ||
| 2024-07-26 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +26,713 | 182,535 |
Page 8 of 18 · 352 trades